MetaCap

AstraZeneca Statistics

NYSE: AZNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

158.71-1.41 (-0.88%)

Market open · Delayed 15 min · as of Oct 8, 3:07 PM ET

AstraZeneca by the numbers

AstraZeneca has a market capitalization of $246.14 billion based on 1.55B shares outstanding. Its trailing P/E ratio is 23.7, below the 8-company peer median of 25.6, and its forward P/E is 13.7. The stock trades 2.4% below its 50-day average and 12.7% below its 200-day average.

Average daily trading volume is 3.42M shares, or about $542.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

AZN valuation vs. peer median

AZN compared with the median of 8 peer companies
MetricAZNPeer medianDifference
Market cap$246.14B$163.18B+51%
P/E (TTM)23.725.6-7%
Forward P/E13.713.0+5%
Dividend yield2.04%4.20%-52%
Avg. volume3.42M9.66M-65%

Peer median across 8 companies: NVS, ABT, NVO, PFE, MRK, VRTX, BMY, SNY.

Valuation

Market cap
$246.14B
Price / sales (latest FY)
4.19

Price and trading

Previous close
160.12
Open
159.80
Day range
156.72 – 160.05
52-week range
153.41 – 212.71
52-week change
-6.77%
Beta
—
Volume
1.67M

Dividends and events

Annual dividend
$3.23
Next earnings date
Oct 30, 2026

Additional statistics

Market Cap
246.14B
Pe
23.72
Forward Pe
13.72
Eps
6.69
Dividend Yield
2.00%
Dividend Rate
3.23
Week52 High
212.71
Week52 Low
153.41
Avg Volume
3.42M
Shares Outstanding
1.55B
Ma50
162.62
Ma200
181.77
Earnings Date
Oct 30, 2026
Pct From52w High
-25.39%
Pct From52w Low
3.45%

Related